3 results for ""TOM MURPHY""
Walgreen booked a $239 million loss in its fiscal fourth quarter after swallowing a huge accounting charge from its Alliance Boots acquisition, but the drugstore chain's results still met Wall Street expectations.
Valeant Pharmaceuticals is drawing attention to a potential glaucoma treatment and its focus on product development, as the Canadian drugmaker continues to build its case to investors for a takeover of Botox-maker Allergan.
Five hospitals sit within an easy drive of my Indianapolis home. It's comforting to know, considering that my wife will deliver our second child in late August.